Print

ADC Therapeutics Appoints Former Genmab A/S (GEN.CO) VP Dr Patrick van Berkel as Senior VP of R&D  
7/17/2012 10:04:33 AM

LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics (ADCT), the drug development company targeting cancers with antibody-drug conjugate (ADC) “warhead” therapies, today announced the appointment of former Genmab Vice President Dr Patrick van Berkel as Senior Vice President, Research & Development.
//-->